Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-operative Regional Heparinization in TKA
NCT00253851Phase 4Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jul 2003
- Primary completion
- May 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in deep vein thrombosis (DVT) comparing Heparin Group with Placebo Group (2 arms). Primary endpoint: Deep Vein Thrombosis. Started Jul 2003; status: completed.
02
Drugs
heparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT00253851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00253851.